🔗 Visit the ClinicalTrials.gov page for NCT00152425
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Maintenance therapy with certolizumab pegol for Crohn's disease. | N Engl J Med | 2007 | 4.56 |
| 2 | Anti-TNF antibodies for Crohn's disease--in pursuit of the perfect clinical trial. | N Engl J Med | 2007 | 1.50 |
| 3 | Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study. | Aliment Pharmacol Ther | 2010 | 1.07 |
| 4 | Certolizumab pegol. | MAbs | 2011 | 0.95 |
| 5 | Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol. | Aliment Pharmacol Ther | 2011 | 0.75 |